Jonathan E. Lim - 23 Jun 2025 Form 4 Insider Report for Boundless Bio, Inc. (BOLD)

Reporting relationship: Director
Issuer ticker: BOLD
Reported as of: 23 Jun 2025
Net transaction value: $0
SEC form: 4
Accepted by SEC: 23 Jun 2025, 17:13:59 UTC
Prior SEC filing: 05 Feb 2025
Next SEC filing: 24 Sep 2025
Source filing: View source filing
Reporting owner signature: /s/ Jessica Oien, Attorney-in-Fact for Jonathan E. Lim

Key filing fact

Jonathan E. Lim filed Form 4 for Boundless Bio, Inc. (BOLD) on 23 Jun 2025.

Key facts

This page summarizes Jonathan E. Lim's Form 4 filing for Boundless Bio, Inc. (BOLD).
1 reported transaction and 1 derivative row are listed below.
Accepted by SEC: 23 Jun 2025, 17:13.

Change

Previous filing in this sequence was filed on 05 Feb 2025.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001283290 Primary reporting owner

Lim Jonathan E

Relationship: Director
Address: C/O BOUNDLESS BIO, INC., 10955 ALEXANDRIA WAY, SUITE 100, SAN DIEGO
Signature: /s/ Jessica Oien, Attorney-in-Fact for Jonathan E. Lim
Signature date: 23 Jun 2025

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

BOLD transaction Derivative

Stock Option (right to buy)

Award

Transaction value: $0
Shares: +24,000
Change %
Price: $0.000000
Shares after: 24,000
Date: 23 Jun 2025
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 24,000
Exercise price: $1.03
Footnotes: F1

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 1 footnote

Footnote F1

The stock option shall vest in substantially equal monthly installments over the 12 months following June 23, 2025 (or, in the event the next annual meeting of the issuer's stockholders occurs prior to June 23, 2026, any remaining unvested portion of the stock option will vest on the date of such annual meeting), subject to the reporting person's continuing service on the issuer's board of directors through such vesting date.